43 min listen
Buying Public Companies
FromM&A Science
ratings:
Length:
33 minutes
Released:
Jul 25, 2022
Format:
Podcast episode
Description
Pranjal Gambhir, and Doretta Mistras, Managing Director - Global Investment Banking, Healthcare at Citi The M&A process varies when dealing with a public vs private company. To many, acquiring a public company is more ideal. First-time acquirers need to be aware of the differences between acquiring a public company and acquiring a private company. In this episode of the M&A Science Podcast, Pranjal Gambhir and Doretta Mistras, both Managing Directors, Global Investment Banking, Healthcare at Citi, talk about how to buy public companies. To check out Affinity’s 2022 M&A Benchmark Report, download it for free at http://affinity.co/kison Liked today's episode? Unlock over 50 courses taught by top-tier M&A practitioners by joining the M&A Science Academy. Use code “podcast” on the sign-up page for a 30% discount, available on either monthly or annual plans. https://www.mascience.com/academy Want to learn about upcoming interviews, events, and industry trends? Sign up for our weekly newsletter. https://www.mascience.com/newsletter-signup If you’re a head of corporate development and looking to build up a world-class M&A team, reach out to me at kison@mascience.com. This episode is sponsored by FirmRoom, the fastest virtual data room used to get deals done. Leave the pay-per-page world behind by going to https://firmroom.com/
Released:
Jul 25, 2022
Format:
Podcast episode
Titles in the series (100)
128. Staying True to Culture in M&A: Trish Mosconi, Executive Vice President, Chief Strategy Officer & Corporate Development at Synchrony (NYSE: SYF) Culture is one of the most controversial and hot topics in the world of M&A. On this episode of M&A Science, Trish Mosconi,... by M&A Science